Search research articles
Contact Us
Filters
Showing results (61-70 of 346) with videos related to
Page
of 35
Sort By:
Transplantation and Cellular Therapy
|
February 15, 2025
Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells
Frederick L Locke, Zahra Mahmoudjafari, Partow Kebriaei, et al.
Leukemia
|
January 12, 2026
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Journal of Visualized Experiments : Jove
|
February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood
M Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
Partow Kebriaei, Jack Hayes, Andrew Daly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2014
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?
Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondon, et al.
Blood Advances
|
June 15, 2025
Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
Yosra M Aljawai, Jeremy Ramdial, Gabriela Rondon, et al.
British Journal of Haematology
|
May 10, 2006
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma
Chitra Hosing, Muzaffar H Qazilbash, Partow Kebriaei, et al.
American Journal of Hematology
|
May 15, 2021
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia
Nitin Jain, Abhishek Maiti, Farhad Ravandi, et al.
JCO Oncology Practice
|
January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Seminars in Oncology Nursing
|
October 11, 2021
The Unique Symptom Burden of Patients Receiving CAR T-Cell Therapy
Meagan S Whisenant, Samer A Srour, Loretta A Williams, et al.
Page
of 35
Search research articles
Search
Showing results (61-70 of 346) with videos related to
Sort By:
Page
of 35
Transplantation and Cellular Therapy
|
February 15, 2025
Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells
Frederick L Locke, Zahra Mahmoudjafari, Partow Kebriaei, et al.
Leukemia
|
January 12, 2026
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Journal of Visualized Experiments : Jove
|
February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood
M Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
Partow Kebriaei, Jack Hayes, Andrew Daly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2014
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?
Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondon, et al.
Blood Advances
|
June 15, 2025
Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
Yosra M Aljawai, Jeremy Ramdial, Gabriela Rondon, et al.
British Journal of Haematology
|
May 10, 2006
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma
Chitra Hosing, Muzaffar H Qazilbash, Partow Kebriaei, et al.
American Journal of Hematology
|
May 15, 2021
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia
Nitin Jain, Abhishek Maiti, Farhad Ravandi, et al.
JCO Oncology Practice
|
January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Seminars in Oncology Nursing
|
October 11, 2021
The Unique Symptom Burden of Patients Receiving CAR T-Cell Therapy
Meagan S Whisenant, Samer A Srour, Loretta A Williams, et al.
Page
of 35